Clinical Trials Market Size Worth Around US$ 84.43 Bn by 2030

According to Precedence Research, the global clinical trials market size is projected to be worth around US$ 84.43 billion by 2030 from at US$ 48.4 billion in 2020, growing at a CAGR of 5.7% from 2021 to 2030.

Ottawa, Jan. 27, 2022 (GLOBE NEWSWIRE) -- The clinical trials market is expanding because to the rising frequency of chronic disorders and the rising demand for clinical trials in developing nations. The clinical trials market is fueled by the increasing number of biologics on the market and the demand for contract research organizations to undertake clinical studies. In addition, various biotechnology and pharmaceutical companies are now conducting clinical trials for severe chronic and infectious disorders such as HIV and cancer, which will help to expand the clinical trials market.

Get the Report Sample Copy@

Regional Snapshot

Asia-Pacific is the largest segment for clinical trials market in terms of region. This is attributed to the growing availability of a broad patient pool, making candidate recruiting easier. The global COVID-19 pandemic is also a major contributor to the clinical trials market expansion.

North America region is the fastest growing region in the clinical trials market. This can be linked to the North America region’s increased research and development adoption of new clinical research technology. Furthermore, favorable government assistance for clinical trials in the U.S. is expected to stimulate demand.

Report Scope of the Clinical Trials Market

Report HighlightsDetails
Market Size by 2030USD 84.43 Billion
CAGR5.7% from 2021 to 2030
Fastest Growing RegionAsia Pacific
Largest Revenue HolderNorth America
Base Year2021
Companies CoveredParexel, IQVIA, Kendle, Charles River Laboratory, Chiltern, Omnicare, Pharmaceutical Product Development, LLC.

Ask here for more customization study@

Report Highlights

  • Based on the phase, the phase III segment dominated the global clinical trials market in 2020 with highest market share. The fact that a phase III study covers a high number of individuals and is the most expensive phase of a trial among all segments contributes to the clinical trials market growth.

  • Based on the study design, the interventional design segment dominated the global clinical trials market in 2020 with highest market share. Interventional studies account largest percentage of all investigations, with the bulk of them using medicines or biologics, followed by clinical procedure, behavioral, and device intervention studies.

  • Based on the indication, the oncology segment dominated the global clinical trials market in 2020 with highest market share. The oncology is the study of tumors. Tumors have the potential to be life-threatening in a large number of individuals, necessitating the development of better and more advanced treatments for diverse forms of tumors.

Get more information about report@

Market Dynamics


Surge in demand for outsourcing clinical trials

The demand for efficient, fast-paced, and trustworthy clinical trials programs is expected to expand as the demand for novel medications and improved medical technologies grows. Furthermore, the medication development process is exceedingly dangerous for biotechnology and pharmaceutical businesses, with much lower approval rates and accompanying expansive expenses. As a result, outsourcing the clinical trials program to several contract research organizations (CRO) has been determined to save the pharmaceutical corporation substantial time and money. Regional penetration of specific contract research organizations (CRO) has also been documented. Thus, the surge in the demand for outsourcing clinical trials is propelling the growth of the clinical trials market growth during the forecast period.


High cost of clinical trials

The clinical trials market’s services are costly. In the forecast period, market labor costs are a restricting factor for the market growth. Patenting and contracting for the clinical trials market is a complicated process. As a result, the clinical trials market’s labor costs are high. The cost is an issue since it reduces demand in a few markets. The clinical trials services must be cost-effective in most businesses. The high cost, on the other hand, raises the industry’s overall operating costs. Thus, the high cost of clinical trials is hindering the growth of the clinical trials market during the forecast period.


Growing use of predictive analytics

Several firms are already using predictive analytics techniques such as artificial intelligence and machine learning to construct models and advise choices. Given the wealth of health data now available to clinical trial investigators, predictive analytics tools can be used in clinical trial design to identify patient characteristics that are more likely to respond to a specific treatment pattern, thereby increasing success rates and lowering risk in large, multi-center clinical trials. As a result, the growing use of predictive analysis is creating lucrative opportunities for the market growth during the forecast period.


Stringent government regulations

Conducting clinical trials in different nations comes with a slew of regulatory challenges that could stymie market growth. The restrictions can be simplified with the cooperation of multiple regulatory authorities, however there is now a slow operating speed. Several nations also demand local language translation, as well as import and export authorization and the presentation of data on local patients. As a result, a complicated regulatory structure complicated regulatory structure combined with a considerable language barrier could stifle regional development.

Browse more healthcare industry research reports@

Major Market Segments Covered:

By Phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

By Study Design

  • Observational
  • Interventional
  • Expanded Access

By Indication

  • Oncology
  • Autoimmune/Inflammation
  • Diabetes
  • Central Nervous System
  • Cardiovascular
  • Pain Management
  • Others

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Click Here to View Full Report Table of Contents

Buy this Premium Research Report@

You can place an order or ask any questions, please feel free to contact at | +1 9197 992 333

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

For Latest Update Follow Us: